DexCom
DXCM
#946
Rank
HK$201.17 B
Marketcap
HK$521.36
Share price
2.27%
Change (1 day)
-23.34%
Change (1 year)

Earnings for DexCom (DXCM)

Earnings in 2026 (TTM): HK$9.52 Billion

According to DexCom's latest financial reports the company's current earnings are HK$4.81 Billion. In 2025 the company made an earning of HK$8.66 Billion, an increase over its 2024 earnings that were of HK$5.70 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for DexCom from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$9.52 B9.92%
2025 HK$8.66 B52.02%
2024 HK$5.70 B-0.37%
2023 HK$5.72 B78.13%
2022 HK$3.21 B47.34%
2021 HK$2.18 B-10.11%
2020 HK$2.42 B88.27%
2019 HK$1.28 B-258.48%
2018 -HK$0.82 Billion189.94%
2017 -HK$0.29 Billion-44.24%
2016 -HK$0.51 Billion12.43%
2015 -HK$0.45 Billion165.58%
2014 -HK$0.17 Billion-25.61%
2013 -HK$0.23 Billion-48.11%
2012 -HK$0.44 Billion24.5%
2011 -HK$0.36 Billion
2008 -HK$0.42 Billion13.18%
2007 -HK$0.37 Billion-5.36%
2006 -HK$0.39 Billion52.08%
2005 -HK$0.26 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.47 B 2,028.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$63.73 B 566.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$49.15 B 414.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
HK$15.42 B 61.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
HK$10.12 B 5.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-HK$1.57 Billion-116.41%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-HK$8.9 Billion-193.11%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
HK$5.25 B-45.05%๐Ÿ‡บ๐Ÿ‡ธ USA